Suven Pharmaceuticals Limited
Stock Forecast, Prediction & Price Target

Suven Pharmaceuticals Limited Financial Estimates

Suven Pharmaceuticals Limited Revenue Estimates

Suven Pharmaceuticals Limited EBITDA Estimates

Suven Pharmaceuticals Limited Earnings per Share Estimates

Passed Analyst forecast
Metric 3/31/2021 3/31/2022 3/31/2024 3/31/2026 3/31/2027
Revenue
 
% change YoY
₹9.79B
 
N/A
₹12.89B
 
31.62%
₹10.51B
 
-18.48%
Avg: ₹14.70B
Low: ₹14.70B
High: ₹14.70B
avg. 39.82%
Avg: ₹17.05B
Low: ₹17.05B
High: ₹17.05B
avg. 15.99%
Net Income
 
% change YoY
₹3.62B
 
N/A
₹4.53B
 
25.24%
₹3.00B
 
-33.83%
Avg: ₹4.56B
Low: ₹4.55B
High: ₹4.70B
avg. 51.97%
Avg: ₹5.41B
Low: ₹0
High: ₹0
avg. 18.68%
EBITDA
 
% change YoY
₹4.56B
 
N/A
₹6.38B
 
39.76%
₹4.67B
 
-26.77%
Avg: ₹7.06B
Low: ₹7.06B
High: ₹7.06B
avg. 50.97%
Avg: ₹8.19B
Low: ₹8.19B
High: ₹8.19B
avg. 15.99%
EPS
 
% change YoY
$14.23
 
N/A
$17.83
 
25.29%
$11.8
 
-33.81%
Avg: $18.2
Low: $17.9
High: $18.5
avg. 54.23%
Avg: $0
Low: $0
High: $0
avg. -100%
Operating Expenses
 
% change YoY
₹1.48B
 
N/A
₹1.91B
 
29.33%
₹1.40B
 
-26.89%
Avg: ₹673.41M
Low: ₹673.41M
High: ₹673.41M
avg. -51.99%
Avg: ₹781.15M
Low: ₹781.15M
High: ₹781.15M
avg. 15.99%

FAQ

What is Suven Pharmaceuticals Limited stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 35.32% in 2026-2027.

We have gathered data from 2 analysts. Their low estimate is 4.55B, average is 4.56B and high is 4.70B.

What is Suven Pharmaceuticals Limited stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 27.91% in 2026-2027.

We have gathered data from 2 analysts. Their low revenue estimate is ₹14.70B, average is ₹14.70B and high is ₹14.70B.

What is Suven Pharmaceuticals Limited stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 27.11% in 2026-2027.

We have gathered data from 2 analysts. Their low earnings per share estimate is $17.9, average is $18.2 and high is ₹18.5.